VYND Stock: Vynleads, Inc. Stock Price, Analysis & Insights
Get live VYND stock price $0.43, comprehensive Vynleads, Inc. stock analysis, charts, news, and expert forecast. Real-time VYND stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Vynleads, Inc. provides health and wellness guidance, primarily within the United States, to individuals navigating pre-diabetes or living with type 2 diabetes. Among its core offerings is the "Lifestyle Blueprint," an online resource featuring dieta...
Company Information
- CEO
- Alex J. Mannine
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Employees
- 1
Contact Information
- Website
- https://www.vynleads.com
- Address
- 596 Herrons Ferry Road
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Higher growth potential with elevated volatility (Beta: 5.05)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Vynleads, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Vynleads, Inc.
- ⚠Investors should consider how Vynleads, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
7.88M
P/E Ratio (TTM)
-43.00
Beta
5.05
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare VYND with peer companies:
- Price
- $0.39
- Market cap
- 7.07M
- Price
- $0.61
- Market cap
- 8.03M
- Price
- $0.80
- Market cap
- 8.35M
- Price
- $0.00
- Market cap
- 1.62M
- Price
- $0.01
- Market cap
- 3.29M
- Price
- $0.22
- Market cap
- 4.09M
- Price
- $0.00
- Market cap
- 21.93K
- Price
- $0.08
- Market cap
- 7.95M
- Price
- $0.03
- Market cap
- 11.90M
- Price
- $0.08
- Market cap
- 6.91M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.